Compare NeoGenomics Inc. Common Stock (NEO) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs ProShares UltraPro QQQ ETF — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while ProShares UltraPro QQQ ETF trades at $71.43 (market cap $38.26B). The key difference: ProShares UltraPro QQQ ETF is far larger — about 17.9× NeoGenomics Inc. Common Stock's market cap, and ProShares UltraPro QQQ ETF is more actively traded (38,965,303 versus 2,228,400). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and ProShares UltraPro QQQ ETF for 25 Days on average.
| NEO | TQQQ | |
|---|---|---|
Market Cap | $2.14B | $38.26B |
Volume | 2,228,400 | 38,965,303 |
Sector | Health | Leveraged / Inverse |
52-Week High | $19.91 | $87.22 |
52-Week Low | $7.19 | $37.89 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $2.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TQQQ trades at $78.81, down 1.0% on the day, with a bullish technical signal from moving averages but neutral oscillators. The leveraged ETF faces mixed sentiment with recent articles highlighting both strong performance during the AI boom and concerns about hidden costs and volatility decay. Support levels are established at $77-$79, with resistance at $81-$82.
The outlook remains volatile with 3x leverage amplifying both gains and losses. Key risks include expense ratios beyond the stated 0.82% and market volatility amplification. Institutional activity shows mixed positioning, with some firms reducing stakes while others add exposure to tech and AI themes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
